BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta

Reuters

2025/04/09

April 9 (Reuters) - Argent BioPharma Ltd RGT.AX:

STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA
STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA
DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES

Further company coverage: RGT.AX

((Reuters.Briefs@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2526824441"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2526824441\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2526824441?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-09 07:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2526824441","market":"nz","top_or_hot":-1,"title":"BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta</title></head><body><p><span>April 9 (Reuters)</span><span> - </span>Argent BioPharma Ltd <span>RGT.AX</span>:</p><ul><li><p>STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA</p></li><li><p>STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA</p></li><li><p>DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES</p></li></ul><p>Further company coverage: <span>RGT.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-09 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta</title></head><body><p><span>April 9 (Reuters)</span><span> - </span>Argent BioPharma Ltd <span>RGT.AX</span>:</p><ul><li><p>STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTA</p></li><li><p>STRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTA</p></li><li><p>DAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARES</p></li></ul><p>Further company coverage: <span>RGT.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1YV:1","article_id":"2526824441","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2526824441","pubTimestamp":1744153945,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In MaltaApril 9  - Argent BioPharma Ltd RGT.AX:STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTASTRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTADAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARESFurther company coverage: RGT.AX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","RGT.AU":"Argent BioPharma Limited"},"translate_title":"简介-Argent Biopharma与马耳他Argent EU GMP工厂签订合作协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGT.AU":0.9},"content_text":"BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In MaltaApril 9 (Reuters) - Argent BioPharma Ltd RGT.AX:STRATEGIC COLLABORATION AGREEMENT FOR ARGENT EU GMP FACILITY IN MALTASTRATEGIC COLLABORATION GRANTING DAVID TRADING EXCLUSIVE RIGHTS TO OPERATE RGT'S FACILITY IN MALTADAVID TRADING GRANTED EXCLUSIVE, IRREVOCABLE OPTION TO ACQUIRE 100% OF FACILITY COMPANY'S SHARESFurther company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}